PAPILOMAVIRUS. Family: PAPOVAVIRIDAE genus: PAPILLOMAVIRUS Genom: ds DNA,

Slides:



Advertisements
Similar presentations
Two dose Q-HPV Vaccine Study
Advertisements

Human Papillomaviruses (HPV): The Background, Current Status and Future of Vaccines to Prevent HPV Infection, Abnormal Genital Lesions and Cervical Cancer.
Papilloma viruses: from tip to tail Tim Palmer.
. Have you ever wondered & ask your self if there is a certain vaccine capable of protecting against cancer?!
Prevention of Cancer Cervix by Vaccination
HPV.  Many risk factors for development of cervical cancer. no routinely used positive predictive biological markers, which identify women at risk of.
Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination Peter L. Stern Journal of Clinical Virology, 2005.
Cervical Cancer and Vaccines
You are the Key to HPV Cancer Prevention Understanding the Burden of HPV Disease, the Importance of the HPV Vaccine Recommendation, and Communicating about.
HPV and Cervical Cancer
Cervical Cancer: Molecular Impact of an Infectious Disease.
Anticipated impact on HPV infection from HPV vaccination programs – cause for optimism Dr Paddy Horner.
Human Papillomavirus (HPV)
Human Papilloma virus testing Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, MASA What is Human Papillomavirus? Human papilloma.
Our memories of Mahabaleswar. CDC - Immunization Update 2006 Satellite Internet Broadcast December, 2006 Cervical Cancer Vaccine - HPV Summarized from.
 Cervical cancer is a malignant tumour deriving from cells of the "cervix uteri", which is the lower part of uterus.  Begins in the lining of the cervix.
HPV: How to prevent your patients from becoming my patients Katina Robison, MD Assistant Professor, Department of Obstetrics & Gynecology Director of Colposcopy.
Cervical Cancer. Cervix Lower part of the uterus Lower part of the uterus Connects the body of the uterus to the vagina (birth canal) Connects the body.
Cervical Cancer By:Marisela Esparza. Cervical Cancer is cancer in the cervix (the lower part of the cervix that connects to the vagina.)
Human Papilloma Virus (HPV) Vaccine.  HPV infection conveys risk of anogenital warts and local symptoms like itch and pain  High risks include cervical.
HPV & Cervical Cancer Frequently Asked Questions HPV & Cervical Cancer Prevention 2009 International Toolkit.
Human Pappiloma Virus DsDNA, Circular genome
Prospects for a Prophylactic HPV Vaccine and Future Implications for Cervical Cancer Screening Dr. Fuat Demirkıran İ.Ü Cerrahpaşa Tıp Fak. Kadın Hast.
SoftPAP® A Novel Collection Device for Cervical Cytology.
P APOVAVIRUS FAMILY (P APOVAVIRIDAE ) : NOW 2 F AMILIES Papillomaviruses and Polyomaviruses.
Prophylactic HPV vaccines to prevent cervical cancer —but what else? Aimee R. Kreimer, Ph.D. National Cancer Institute March 20,
Facts and Prevention Presented By: Ashley Austin-Yearwood, John Cyril Quarshie, Lauren Decker, Jamison Halliwell.
The New HPV Vaccine Laura Zakowski, MD No conflicts of interest.
A non-enveloped DNA virus which infects the skin/ mucous membranes of humans.
HPV American Society of Reproductive Medicine New Orleans, October 2006.
HPV and Cervical Cancer FAQ. What is cervical cancer? Cervical cancer is cancer of the cervix, the part of the uterus or womb that opens to the vagina.
Meg Fisher, MD Medical Director
Cervical Cancer. Female Gynecologic Cancers Cervical Cancer.
Cervical Cancer Screening Guidelines Update
The Second Cancer Vaccine: Human Papillomavirus Vaccine Meg Fisher, MD Medical Director.
Human Papillomavirus (HPV). Wed, Nov Tanjung Jaya, Indonesia.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Preventing Cervical Cancer: Human Papillomavirus (HPV) Vaccine
What you need to know about cervical cancer. Cervical Cancer Statistics  United States  An estimated 12,000 new cases each year  An estimated 4,000.
Cervical Cancer: Experiences from a Cohort of HIV-infected Women Pascoe M, Magure T, Mudhokwani P et al Abstract: MOAB0202.
CERVICAL CANCER PREVENTION STRATEGIES Z Mike Chirenje MD FRCOG Department of Obstetrics and Gynaecology University of Zimbabwe, Harare Zimbabwe
Strategies for Monitoring the Impact of HPV Vaccination Using Population-Based Data Rain Mocello, MPH California DPH STD Control Branch.
“Take the Test: Not the Risk” HPV and Cervical Cancer Cervical Cancer is Preventable!
Chapter 29 Human Papilloma Virus Infection and Immunity.
The HPV Vaccine Post- Licensure: Have Online News Stories Changed Over Time? A Follow-up Study. March 30, 2009 Presented by: Jillian R. Doss, MPH, Public.
Cervical Cancer. What is Cancer? Hippocrates was the first to use the word “cancer” to describe tumors Cancer is derived from the Greek word “karkinos”
Viruses Linked With Cancers Mrs. Stewart Medical Interventions Central Magnet School.
Understanding the Interplay between HIV and Ageing, NCDs and Malignancies: Cancer in people with HIV Andrew Grulich HIV Epidemiology and Prevention Program,
Montana Academy of PAs CME conference Elyse Watkins, DHSc, MS, PA-C
Seroprevalence, prevalence, type and factors associated with HPV infection at multiple sites in young HIV-positive MSM On behalf of the HPV MAPS Research.
Cancers Linked to HPV Presenter: Chuck Lynch
Clairette RAHARISOLO VOLOLONANTENAINA1 ,
Human Papillomavirus Kenneth McCall, BSPharm, PharmD, BCGP
NHS CANCER SCREENING PROGRAMMES
HPV VACCINATION ——1st vaccine against cancer
HPV VACCINES Dr. Kirtan Krishna.
Why should we eradicated Cervical cancer?
Dr Sam Hibbitts HPV Research Team Obstetrics & Gynaecology
HPV and Zoster, Etc. MedCh 401 Lecture 9 2Jun06 KL Vadheim Lecture 9.
واکسیناسیون ویروس پاپیلوم انسانی
Nat. Rev. Clin. Oncol. doi: /nrclinonc
A Possible Vertical Transmission of Human Papillomavirus Genotypes Associated with Epidermodysplasia Verruciformis  Michel Favre, Slavomir Majewski, Nando.
Association between Betapapillomavirus Seropositivity and Keratinocyte Carcinoma— Prospects for Prophylactic Vaccination?  Herbert Pfister  Journal of.
Necessity of A Centralized Cervical Cancer Screening Program in IRAN
Risk of cervical precancerous lesions associated with high-risk HPV infection according to MAVS rs status. Risk of cervical precancerous lesions.
Risk of type 2 diabetes as a function of ABCA1 and ABCG1 genotype in CCHS. Hazard ratios were multifactorially adjusted for age, sex, BMI, hypertension,
Cervical Cancer Katie Redmon, BSN, RN
Human Papillomavirus Genotypes in Invasive Cervical Carcinoma in HIV-Seropositive and HIV-Seronegative Women in Zimbabwe.   Presenting author: Dr Alltalents.
Presentation transcript:

PAPILOMAVIRUS

Family: PAPOVAVIRIDAE genus: PAPILLOMAVIRUS Genom: ds DNA,

(HPV typs 1-4, 7, 10, 26-28)

2. Epidermodysplasia verruciformis (HPV types 5, 8, 9, 12, 14, 15, 17, 19-25) malignat HPV

Ca cervix uteri, Ca vulvy, Ca penis (Ca – carcinoma) - 65 % HPV 16 and % HPV 31, 33, 35, 45, 52, 58 High risk genotypes - High risk genotypes - Probably high risk genotypes - Probably high risk genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 58, 59 26, 53, 66, 68, 73, 82 - Low risk genotypes - Low risk genotypes HPV 6, 11, 40, 42, 43, 44, 54, 61, 70, 72, 81 Munoz et al., Vaccine, 2006

Risk factors  Smoking  Contraceptives  HIV

cases Ca cervix uteri/year

Imunocytochemistry Imunocytochemistry capsid Ag capsid Ag Detection DNA Detection DNA Dg. Papanicolaou

Gardasil (Merck) (vakcine – HPV 6, 11, 16, 18) Merck Cervarix (GlaxoSmithKline) (vakcine - HPV 16, 18) GlaxoSmithKline Prevention